BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15575532)

  • 1. [Natural and preformed physical factors in the treatment of late complications in diabetes mellitus type 2].
    Topuria DI
    Vopr Kurortol Fizioter Lech Fiz Kult; 2004; (5):20-2. PubMed ID: 15575532
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of type 2 diabetes: one extreme to another.
    Zaidi S
    Arch Intern Med; 2009 Jul; 169(13):1246-7; author reply 1247. PubMed ID: 19597079
    [No Abstract]   [Full Text] [Related]  

  • 3. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
    Sheffield CA; Kane MP; Busch RS
    Pharmacotherapy; 2007 Oct; 27(10):1449-55. PubMed ID: 17896900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of type II diabetes].
    Curchod B; Chevaux F
    Rev Med Suisse Romande; 1988 Jul; 108(7):559-64. PubMed ID: 3045938
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients.
    Mayorov AY; Naumenkova IV; Antsiferov MB; Dedov II
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S54-9. PubMed ID: 15955377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients.
    Ballani P; Tran MT; Navar MD; Davidson MB
    Diabetes Care; 2006 Nov; 29(11):2504-5. PubMed ID: 17065692
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus.
    Crasto W; Jarvis J; Hackett E; Nayyar V; McNally PG; Davies MJ; Lawrence IG
    Postgrad Med J; 2009 Apr; 85(1002):219-22. PubMed ID: 19417173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetes in the aged--senile diabetes].
    Schliack V
    Z Arztl Fortbild (Jena); 1989; 83(11):579-81. PubMed ID: 2672629
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined treatment with exercise training and acarbose improves metabolic control and cardiovascular risk factor profile in subjects with mild type 2 diabetes.
    Wagner H; Degerblad M; Thorell A; Nygren J; Ståhle A; Kuhl J; Brismar TB; Ohrvik J; Efendic S; Båvenholm PN
    Diabetes Care; 2006 Jul; 29(7):1471-7. PubMed ID: 16801564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study.
    Gao Y; Guo XH; Vaz JA;
    Diabetes Obes Metab; 2009 Jan; 11(1):33-40. PubMed ID: 18494806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperinsulinaemia and iron perturbation in patients with type 2 diabetes.
    Mascitelli L; Pezzetta F; Goldstein MR
    Int J Clin Pract; 2009 Apr; 63(4):672. PubMed ID: 19335710
    [No Abstract]   [Full Text] [Related]  

  • 12. Type 2 diabetes mellitus in childhood: obesity and insulin resistance.
    Schwartz MS; Chadha A
    J Am Osteopath Assoc; 2008 Sep; 108(9):518-24. PubMed ID: 18806081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes.
    Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K
    Arch Med Res; 2006 Aug; 37(6):736-43. PubMed ID: 16824933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of treatment of patients with diabetes mellitus type 2 associated with obesity and gout].
    Ponikowska I; Bielska K; Owczarek L
    Pol Tyg Lek; 1984 Dec; 39(49):1593-6. PubMed ID: 6522318
    [No Abstract]   [Full Text] [Related]  

  • 15. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
    Inzucchi SE
    Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
    [No Abstract]   [Full Text] [Related]  

  • 16. Weight gain in type 2 diabetes mellitus--not all uphill.
    Cohen O; Norymberg C; Neumann E; Dekel H
    Diabetes Res Clin Pract; 2008 Jan; 79(1):128-32. PubMed ID: 17720273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An algorithm for the treatment of type 2 diabetes in Latin America.
    Chacra AR; Davidson JA; Diaz J; Escalante-Pulido M; Litwak LE; Mestman JH; More L; Violante RM
    Diabetes Obes Metab; 2005 Mar; 7(2):148-60. PubMed ID: 15715888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic effects of once daily extended-release metformin in patients with type 2 diabetes: a multicentre study.
    Gao H; Xiao W; Wang C; Zhang J; Yang Y; Yang J; Yang W; Hong T
    Int J Clin Pract; 2008 May; 62(5):695-700. PubMed ID: 18412932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biliary pathology in patients with type 2 diabetes mellitus and methods for its correction with the use of health resort and spa factors].
    Danilova ML; Trusov VV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2011; (3):15-8. PubMed ID: 21837834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.